AURKA and non-small cell lung carcinoma: Our results demonstrated that miR-32 can suppress NSCLC by targeting AURKA (Figure 3B/3C, Figure 4) and it has been published that AURKA can suppress the effects of p53 [52, 53], an anti-oncogene which can up-regulate the expression level of miR-34a [54].